Population pharmacogenetics of Ibero-Latinoamerican populations (MESTIFAR 2014)

Pharmacogenomics. 2015;16(7):673-6. doi: 10.2217/pgs.15.32. Epub 2015 May 1.

Abstract

MESTIFAR 2014 28-30 November 2014, Panama City, Panama The CEIBA consortium was created within the Ibero-American network of Pharmacogenetics (RIBEF) to study population pharmacogenetics. The current status of these initiatives and results of the MESTIFAR project were analyzed in Panama, 28-30 November 2014. The MESTIFAR project focused on studying CYPs genetic polymorphisms in populations of different ethnic origin. So far, more than 6000 healthy volunteers have been evaluated, making this one of the largest population pharmacogenomic studies worldwide. Three symposia were organized, 'Pharmacogenetics of indigenous and mestizos populations and its clinical implications', 'Methodological innovation in pharmacogenetics and its application in health', and 'General discussion and concluding remarks', about mechanisms and proposals for training, diffusion of pharmacogenetics for Spanish- and Portuguese-speaking health professionals, and 'bench to bedside' pilot projects.

Keywords: Ibero-Americans populations; cytochrome P450; drug metabolism; genome-wide analyses; metabolic phenotypes; next-generation sequencing; pharmacogenetics; population genetics.

Publication types

  • Congress
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Hispanic Americans / genetics*
  • Humans
  • Indians, Central American / genetics*
  • Indians, South American / genetics*
  • Panama
  • Pharmacogenetics / methods
  • Pharmacogenetics / trends*
  • Population Surveillance* / methods